UPMC Enterprises

Corporate

Portfolio

companies

Ultromics

Ultromics develops artificial intelligence tools to detect hidden heart disease.

Series C31 July 2025

$55.0M

Ultromics raises $55m in Series C funding led by Lightrock, Legal and General, and Allegis Capital to expand its artificial intelligence diagnostics platform.

The Oxford spinout secured backing from a group of healthcare investors to scale its EchoGo heart disease detection technology.

"Hospitals already possess the data; they just lack the tools to unlock its full diagnostic potential."

— Ross Upton, Founder

Lightrock + 9 others